KARL STORZ Endoscopy-America, Inc. Unveils Innovative Diagnostic Modality For Lung Cancer; Advanced Technology Uses Novel Combination Of Bronchoscopy And Special Light Spectrum
10/19/2005 5:11:44 PM
Karl Storz Endoscopy-America, Inc., a world leader in diagnostic and operative minimally invasive endoscopic technology, announces the D-Light Autofluorescence (AF) Bronchoscopy System for the early detection of lung cancer. Early detection provided by this combination of state-of-the-art endoscopy and the unique capabilities of autofluorescence technology may enable physicians to treat this malignancy at an early stage. Karl Storz remains the only U.S. company currently marketing an FDA-approved autofluorescence bronchoscopy system.
comments powered by